Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Oral presentation

New mechanisms of action and signaling by TNF-α

Author: Lionel B Ivashkiv

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

TNF-α is a key pathogenic factor in inflammatory arthritis. Rapid and transient signaling and functional responses of cells to TNF-α, such as activation of NF-γB and MAPKs, are well known. These signaling mechanisms are widely assumed to be functional in cells chronically exposed to TNF-α and to mediate the pathogenic effects of TNF-α in chronic inflammation. We investigated the responses of primary macrophages to TNF-α over the course of several days and compared patterns of signaling and gene expression to RA synovial macrophages. The acute inflammatory response to TNF-α subsided after several hours and was followed by an IFN response characterized by sustained expression of STAT1 and downstream target genes. TNF-α-mediated induction of an IFN response was mediated by IFN-β and was sensitive to inhibition by Jak inhibitors. Concomitantly TNF-α induced a state of macrophage resistance to the homeostatic cytokines IL-10 and IL-27. Microarray analysis demonstrated that sustained TNF-α signaling induced expression of novel genes not appreciated to be 'TNF-inducible', but are highly expressed in RA synovial macrophages. Induction of an IFN response and abrogation of homeostatic cytokine signaling was also observed in RA synovial macrophages and likely contributes to the pathogenic actions of TNF-α during arthritis. …
Metadata
Title
New mechanisms of action and signaling by TNF-α
Author
Lionel B Ivashkiv
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3590

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.